立体定向脑电图模式与射频热凝治疗下丘脑错构瘤长期癫痫预后
研究纳入30例下丘脑错构瘤相关癫痫患者,接受立体定向脑电图引导射频热凝并随访至少3年,平均随访69.2个月。末次随访时20例(66.7%)达无发作(ILAE 1-2级),立体定向脑电图局灶低波幅快活动与短期和长期无发作均相关。
要点
- 下丘脑错构瘤患者行立体定向脑电图引导射频热凝后,末次随访66.7%(20/30)达无发作(ILAE 1-2级)。
- 立体定向脑电图记录到局灶低波幅快活动的癫痫发作,短期(p=0.021)和长期(p=0.022)均更易达无发作。
- 有下丘脑错构瘤切除史可能对长期预后产生负面影响,而病灶位置、体积、发作类型或发作时长对短期和长期预后均无显著影响。
核心结论
- 立体定向脑电图信号可指导下丘脑错构瘤消融,并作为短期和长期癫痫良好预后的重要预测因素,而其他因素迄今未显示此能力。
- 对于有下丘脑错构瘤切除史但仍存在非痴笑性发作的患者应谨慎考虑,可能机制为发作网络再形成,可部分解释痴笑性发作与非痴笑性发作患者的预后差异及继发性癫痫发生进展。
研究设计与样本
- 研究纳入30例下丘脑错构瘤相关癫痫患者,接受立体定向脑电图引导射频热凝,并随访至少3年。
- 癫痫预后采用国际抗癫痫联盟(ILAE)分类评估,1级和2级定义为无发作。
- 根据观察到的复发时间,将术后1年内随访定义为短期随访,分别分析病灶特征、癫痫特征和立体定向脑电图模式与短期和长期无发作的关系,并报告长期并发症。
主要发现
- 自首次射频热凝后平均随访69.2个月(范围36-107个月)。
- 末次随访时20例(66.7%)达无发作(ILAE 1级和2级)。
- 痴笑性发作患者中81.8%(18/22,2例复发后)达无发作,其他类型发作(即非痴笑性发作)患者中52.9%(9/17,4例复发后)达无发作。
- 立体定向脑电图记录到局灶低波幅快活动的癫痫发作,短期(p=0.021)和长期(p=0.022)均更易达无发作。
- 有下丘脑错构瘤切除史可能对长期随访预后产生负面影响,而病灶位置、体积、发作类型或发作时长对短期和长期预后均无显著影响。
临床怎么用
- 作者认为,立体定向脑电图信号可指导下丘脑错构瘤消融,并作为短期和长期癫痫良好预后的重要预测因素。
- 作者认为,对于有下丘脑错构瘤切除史但仍存在非痴笑性发作的患者应谨慎考虑。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to investigate the long-term outcomes and clinical predictors for seizure freedom in patients with hypothalamic hamartomas (HHs) undergoing radiofrequency thermocoagulation (RFTC) guided by stereo-electroencephalography (SEEG). METHODS: The authors enrolled 30 patients with HH-related epilepsy who underwent SEEG-guided RFTC and were followed up for at least 3 years. Seizure outcomes were assessed using the International League Against Epilepsy (ILAE) classification, with classes 1 and 2 defined as seizure freedom. Considering the observed time to relapse, the authors defined postoperative follow-up within 1 year as short-term follow-up. They analyzed lesion features, epileptic characteristics, and SEEG patterns for their relationship with short-term and long-term seizure freedom separately. Long-term complications were also reported. RESULTS: The mean follow-up was 69.2 months (range 36-107 months) since the first RFTC. At the last follow-up, 20 patients (66.7%) achieved seizure freedom (ILAE classes 1 and 2). Regarding different seizure types, freedom was achieved in 81.8% of patients (18/22, after 2 cases relapsed) with gelastic seizures (GS) and in 52.9% patients (9/17, after 4 cases relapsed) with other types of seizures (i.e., nongelastic seizures [NGS]). Seizures characterized by focal low-voltage fast activity recorded by SEEG were more likely to achieve freedom both in the short term (p = 0.021) and the long term (p = 0.022). A history of HH resection might negatively impact a patient's outcome at long-term follow-up, whereas lesion location, volume, seizure types, or the seizure duration showed no significant influence on both short-term and long-term outcomes. Weight gain was the most common long-term complication (26.7%). CONCLUSIONS: The SEEG signal can guide HH ablation and serve as an important predictor for favorable seizure outcomes in both the short term and long term, a capability not exhibited by other factors thus far. Patients with a history of HH resection but who still experience NGSs should be considered carefully, as there may be a speculated mechanism of an NGS network re-forming, which can partly explain the outcome difference between patients with GSs and those with NGSs, as well as the progression of secondary epileptogenesis.
引用
- Liu C, Wang X, Zheng Z, et al. Stereo-electroencephalography pattern and long-term seizure outcome in hypothalamic hamartoma treated by radiofrequency thermocoagulation. J Neurosurg. 2025. PMID: 39919283. doi:10.3171/2024.9.JNS241261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。